Health
Researchers develop promising new drug candidates to treat ALS – Drug Target Review
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Posted: 2 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Scientists report that they have taken a significant step forward in the search to find effective new drugs for the treatment of Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease.
Researchers from the University of Liverpool, UK, and University of Nagoya, Ja…
-
General19 hours agoToni Lamond, known for her roles in Annie Get Your Gun and My Fair Lady, dies aged 93
-
General20 hours agoPolice continue search for missing man Chris Thorne in Melbourne’s west
-
Noosa News22 hours agoPeregian Square revitalised | Noosa Today
-
Noosa News23 hours agoRegional media calls for unity on News Bargaining incentive